CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Aarti Drugs Ltd

Aarti Drugs Ltd

BSE 524348 AARTIDRUGS INE767A01016
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

14 filings · 5 material · busiest 2026-07-31

What it files

Analyst / Investor Meet4 Board Meeting2 Trading Window1 General1 Concall Transcript1 Newspaper Publication1 Results1 Board Outcome1

Filings

14 in the window

  1. 24 August 2026

    Board Meeting

    Board Meeting Intimation for 'Aarti Drugs Limited - Performance Stock Option Plan 2026',

    Aarti Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 ,inter alia, to consider and approve 'Aarti Drugs Limited - Performance ....

    Board Meeting / Board Meeting View filing →

  2. 24 August 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 14 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Analyst/ Institutional Meet

    Company Update / Analyst / Investor Meet View filing →

  4. 10 August 2026

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

    Disclosure under Regulation 30 of SEBI Listing Regulations

    Company Update / General View filing →

  5. 7 August 2026

    Concall Transcript

    Earnings Call Transcript

    Q1FY27 Earning call transcript

    Company Update / Earnings Call Transcript View filing →

  6. 4 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Analyst /Institutional Investors Meeting

    Company Update / Analyst / Investor Meet View filing →

  7. 3 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication on Financial results

    Company Update / Newspaper Publication View filing →

  8. 3 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Q1FY27 Earning Conference call recording

    Company Update / Analyst / Investor Meet View filing →

  9. 31 July 2026

    Results

    Financial Results For The Quarter Ended June 30, 2026

    Financial Results for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  10. 31 July 2026

    Board Outcome

    Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2026

    Financial Results for the quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  11. 31 July 2026

    Change in Directorate

    Change in Directorate

    Change in Directorate

    Company Update / Change in Directorate View filing →

  12. 31 July 2026

    Press Release

    Press Release / Media Release

    Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-term Strategic Growth

    Company Update / Press Release / Media Release View filing →

  13. 29 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Q1 Earning Conference Call

    Company Update / Analyst / Investor Meet View filing →

  14. 24 July 2026

    Board Meeting

    Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026

    Aarti Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Financial results for the quarter ....

    Board Meeting / Board Meeting View filing →